Pfizer and GSK’s New RSV Vaccines On Track For $2 Billion in Sales
GSK Plc and Pfizer Inc. are on pace to sell a combined $2 billion of their new RSV
2023-10-02 14:20
British Gas Owner Boosts Shareholder Returns: The London Rush
Centrica is boosting shareholder returns after profit at its British Gas business increased almost 10-fold compared to last
2023-07-27 15:51